EUVIMEDDescubrir EUVIMED
Fallbericht

Bioprosthetic aortic valve thrombosis under effective direct oral anticoagulant therapy

Arda Guler iD, Yunus Emre Erata, Sinem Aydin iD, Haci Murat Gunes, Gamze Babur Guler iD

Echocardiography · 2023

DOI: 10.1111/echo.15642 ↗

At a glance

Fallbericht in Echocardiography, 2023. Written by Arda Guler and 4 co-authors. Institution: Department of Cardiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospita…. Major MEDLINE topics: Thrombosis, Thromboembolism, Heart Valve Prosthesis, Bioprosthesis. Cited 2 times so far (Crossref); 17 references.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

With the increase in transcatheter procedures, the use of bioprosthetic valves has become more frequent in clinical practice. However, the optimal antithrombotic management of patients with bioprosthetic valves remains controversial. In this case report, we describe a patient with a bioprosthetic aortic valve who developed a thrombus while receiving effective dose direct oral anticoagulant (DOAC) therapy. A 73‐year‐old male patient with a bioprosthetic aortic valve replacement 2 years prior presented with a mobile thrombus and early degeneration of the valve, detected during routine follow‐up while being treated with apixaban. Although the valve thrombus regressed after switching to a different anticoagulant drug, we observed that the decreased but still high gradient persisted due to the early degeneration. Anticoagulant management of bioprosthetic valve patients demands careful attention. Although evidence supporting the use of DOACs is growing, close patient follow‐up and further evaluation in case of doubt remain critical. The development of a thrombus in a bioprosthetic valve patient who is receiving anticoagulation therapy, as in this case, highlights the need for optimal management to prevent thromboembolic complications and valve degeneration.

Subjects

MeSH terms (MEDLINE)

ThrombosisThromboembolismHeart Valve ProsthesisBioprosthesisMaleHumansAgedAortic ValveAnticoagulants

Author keywords

DOACbioprosthetic aortic valvevalve thrombosis

Substances

Anticoagulants

Authors and institutions

  • Department of Cardiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
  • Department of Radiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
  • Department of Cardiology, Medipol University Faculty of Medicine, Istanbul, Turkey.

ORCID profiles: Arda Guler, Sinem Aydin, Gamze Babur Guler

Cite

APA

Guler, A., Erata, Y. E., Aydin, S., Gunes, H. M., & Babur Guler, G. (2023). Bioprosthetic aortic valve thrombosis under effective direct oral anticoagulant therapy. Echocardiography. https://doi.org/10.1111/echo.15642

Vancouver

Guler A, Erata YE, Aydin S, Gunes HM, Babur Guler G. Bioprosthetic aortic valve thrombosis under effective direct oral anticoagulant therapy. Echocardiography. 2023. doi:10.1111/echo.15642

BibTeX
@article{Guler2023,
  author = {Guler, Arda and Erata, Yunus Emre and Aydin, Sinem and Gunes, Haci Murat and Babur Guler, Gamze},
  title = {Bioprosthetic aortic valve thrombosis under effective direct oral anticoagulant therapy},
  journal = {Echocardiography},
  year = {2023},
  doi = {10.1111/echo.15642}
}
Start for free →